What is Day By Day (DBD) crypto coin? Token explained with real market data

Day By Day (DBD) is a cryptocurrency token built to power a decentralized insurance marketplace. Unlike most crypto projects that focus on payments or DeFi lending, DBD tries to solve a real-world problem: how to insure physical assets like cars, electronics, or even jewelry using blockchain technology. The idea is simple - replace traditional insurance paperwork with NFTs that represent your policy, and let smart contracts handle claims automatically. But here’s the catch: as of late 2023, this system doesn’t actually work in practice.

How DBD is supposed to work

According to its whitepaper, Day By Day is designed as a DAO-governed platform where users can buy insurance for real assets by linking them to an NFT. If your phone gets stolen, you upload proof - like a police report or serial number - and the smart contract checks it against the NFT policy. If everything matches, the payout happens automatically. Insurers - individuals or small firms - can pool money into claims funds and earn returns when claims are paid out. Token holders use DBD to pay premiums, vote on governance proposals, and stake in liquidity pools to earn rewards.

The token runs on Ethereum as an ERC-20 standard, with the contract address 0xa5f1dbb0e55bc31f32c6d032bee330288490e722. It has a fixed supply of 800 million tokens, and all of them are already in circulation. That’s unusual. Most tokens have a slow release schedule to incentivize early adopters. DBD released everything at once.

Current market reality

As of November 2023, DBD trades between $0.00317 and $0.003771. CoinDesk recorded a price of $0.0033 on November 27. That’s down over 99% from its all-time high of $0.40, according to LiveCoinWatch. The token’s market cap is listed as $0 on Binance and CoinCarp. That’s not a typo. It means no one is willing to pay enough for it to register a value on major platforms.

Trading volume is extremely low. Binance reports $84,415 in 24-hour volume. CoinGecko says $18,101. For comparison, Nexus Mutual - a similar insurance-focused token - trades over $32 million daily. DBD’s volume is less than 0.3% of that. Most of the trading happens on BitMart, where 99.97% of all DBD trades occur.

Users report being unable to sell their tokens. On Bitcointalk, traders say orders over $500 often fail because there’s no one buying. Slippage is brutal - you might set a sell price of $0.0035 and end up getting $0.0028 because the order book is so thin. Some say they’ve held DBD for months and can’t exit without losing half their investment.

The app that doesn’t exist

DBD’s website and whitepaper mention a mobile app called the “asset registry app,” available on iOS and Android. But when you download it, there’s no insurance functionality. No way to link an asset. No NFT policy creation. No claim submission. Just a blank screen with a logo and a link to their Telegram. The app feels like a placeholder. Not a product.

There’s no public GitHub repository for the code. No developer updates. No changelogs. No announcements. The project hasn’t posted a meaningful update since mid-2023. The official Telegram has just over 1,200 members - tiny for a crypto project with a whitepaper that claims to revolutionize insurance.

Why investors are skeptical

People who bought DBD early are now stuck. The token’s design makes it hard to exit: 100% supply is circulating, so there’s no future token release to create hype. No team is actively building. No partnerships have been announced. No real insurance policies have been issued. That’s a red flag.

On Reddit, users ask: “How can a project have a max supply of 800 million and zero market cap?” The answer: because no one believes it’s worth anything. The promise of staking rewards and claim pool investments sounds good on paper, but without actual claims being paid, it’s just speculation.

Even the token’s utility is unclear. You can use DBD to buy gift cards? Monetize insured assets? Reputation scoring? These features sound like buzzwords tacked on to make the project seem more advanced than it is. None are functional. None are documented in detail.

Is DBD a scam?

It’s not officially labeled a scam. No regulatory action has been taken. But it fits the pattern of a “dead project.” The team disappeared. The product doesn’t work. The community is silent. The price is collapsing. And the only thing left is a token with no use case and no liquidity.

Compare this to Nexus Mutual or InsurAce. Both have processed thousands of real insurance claims. Both have active developer teams, public roadmaps, and partnerships with real insurers. DBD has none of that. It’s a whitepaper with a token attached - not a functioning business.

Who should avoid DBD

If you’re looking to invest in blockchain insurance, DBD is not the way. The sector is growing - PwC estimates it’ll hit $1.2 billion by 2023 and grow 42% annually. But DBD is not part of that growth. It’s a footnote.

Don’t buy DBD if you need liquidity. Don’t buy it if you want to use insurance services. Don’t buy it if you expect returns from staking. The only reason to hold it is if you believe someone else will pay more for it tomorrow - a classic pump-and-dump scenario.

What DBD teaches us

DBD is a case study in how not to build a crypto project. It had a solid idea: blockchain-based insurance using NFTs. But execution failed at every level. No product. No team. No community. No liquidity. No updates. It’s not just underperforming - it’s inactive.

Real blockchain projects don’t rely on hype. They ship code. They pay claims. They grow users. DBD did none of that. And now, it’s fading into obscurity.

If you’re researching crypto tokens, look for projects that show progress, not promises. Check GitHub. Check community size. Check if claims have been paid. Check if the team talks publicly. DBD fails every single one of those tests.

If you’re looking for real blockchain insurance, skip DBD. Look at Nexus Mutual, InsurAce, or Etherisc. They have track records. DBD has a whitepaper and a price chart that’s been falling for over a year. Don’t confuse a dead project with an opportunity.